Concurrently, we observed significantly reduced levels of IL6, DAMs, and gliosis in AD brains following treatment with hNSC‐ and iMGL‐EVs, indicating an anti‐inflammatory effect of EVs and EV‐derived cargo, including miRs. Here, IL6 is linked to Alzheimer disease.